Anika Therapeutics (ANIK) has received marketing approval for MONOVISC from the US Food and Drug Administration (FDA) for the treatment of patients suffering from osteoarthritis (OA) of the knee. MONOVISC is a single injection supplement ...
Tags: FDA Approval, Anika
The Federation of State Medical Boards (FSMB) and FSMB Foundation are collaborating with several partners to provide state medical boards with resources to educate health care professionals on the safe and responsible prescribing of ...
Not prescribing opioids first or as a long-term therapy for chronic, non-cancer pain and avoiding MRIs, CTs and X-rays for low-back pain are among the tests and treatments identified by ASA that are commonly ordered but not always ...
Alsa Refinish, a California-based company, has process and utility patent applications in place for a medication delivery method. If successful, Alsa will hold patents for a device that delivers medications and herbal preparations ...
Tags: Alsa Refinish, Medication Delivery
Posted by Jack Mans, Plant Operations Editor -- Packaging Digest, 4/23/2013 5:04:22 PM The U.S. Food and Drug Administration today approved updated labeling for Purdue Pharma L.P.'s reformulated OxyContin (oxycodone hydrochloride ...
Zimmer Holdings has introduced new injectable pain relief gel, Gel-One Hyaluronate, for knee arthritis patients who failed to respond to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs or analgesics. The low-volume ...
Tags: pain relief, knee arthritis, treatment
Kyowa Hakko Kirin, Orexo's partner, has filed a new drug application (NDA) seeking Japanese approval for KW-2246 as cancer pain medication. The sublingual formulation of fentanyl earlier gained approval in US, EU and Canada as cancer ...
Tags: new drug application, cancer pain medication, pharmaceutical product
Valeant Pharmaceuticals has signed an agreement to obtain certain assets from Atlantis Pharma, including products in the gastro, analgesics and anti-inflammatory therapeutic categories, for approximately $71m. The transaction is expected ...
Tags: Valeant Pharmaceuticals, analgesics, anti-inflammatory therapeutic
Pernix Therapeutics has entered into a definitive agreement to acquire Cypress Pharmaceuticals and Hawthorn Pharmaceuticals in Madison, Mississippi, US. Hawthorn offers branded drugs including allergy, respiratory, iron deficiency, ...
Tags: Pernix Therapeutics, Cypress Pharmaceuticals, Hawthorn Pharmaceuticals
Orexo and ProStrakan Group have reconfigured the commercial rights to the product, Abstral, in various territories worldwide. Abstral is the novel, rapidly-disintegrating, sublingual (under the tongue) formulation of fentanyl, and an ...
Royer Biomedical(RBI)wins FDA approval to progress human testing of AppliGel-G(Gentamicin)in management of diabetic foot ulcers(DFU). The patented proprietary dissolvable non-immunogenic polymer drug delivery system platform has ...